Cargando…

NLRP3 Inflammasome Modulation by Melatonin Supplementation in Chronic Pristane-Induced Lupus Nephritis

Lupus nephritis (LN) is a kidney inflammatory disease caused by systemic lupus erythematosus (SLE). NLRP3 inflammasome activation is implicated in LN pathogenesis, suggesting its potential targets for LN treatment. Melatonin, an endogenous indoleamine, is considered an important multitasking molecul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bonomini, Francesca, Dos Santos, Mariane, Veríssimo Veronese, Francisco, Rezzani, Rita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678949/ https://www.ncbi.nlm.nih.gov/pubmed/31311094 http://dx.doi.org/10.3390/ijms20143466

Ejemplares similares

Melatonin as an Anti-Inflammatory Agent Modulating Inflammasome Activation
por: Favero, Gaia, et al.
Publicado: (2017)

The Role of NLRP3 Inflammasome in Lupus Nephritis
por: Oliveira, Camila Barbosa, et al.
Publicado: (2021)

Basophils contribute to pristane-induced Lupus-like nephritis model
por: Dema, Barbara, et al.
Publicado: (2017)

Regulatory Effect of Melatonin on Cytokine Disturbances in the Pristane-Induced Lupus Mice
por: Zhou, Ling-ling, et al.
Publicado: (2010)

Dietary Melatonin Supplementation Could Be a Promising Preventing/Therapeutic Approach for a Variety of Liver Diseases
por: Bonomini, Francesca, et al.
Publicado: (2018)

Role of NLRP3 Inflammasome in Lupus Nephritis and Therapeutic Targeting by Phytochemicals
por: Wu, Dantong, et al.
Publicado: (2021)

Melatonin Modulates the SIRT1-Related Pathways via Transdermal Cryopass-Laser Administration in Prostate Tumor Xenograft
por: Bonomini, Francesca, et al.
Publicado: (2023)

Mitochondrial Dysfunction in Skeletal Muscle of a Fibromyalgia Model: The Potential Benefits of Melatonin
por: Favero, Gaia, et al.
Publicado: (2019)

Anti-complement factor H (CFH) autoantibodies could delay pristane-induced lupus nephritis
por: Li, Lin-Lin, et al.
Publicado: (2023)

Oral Supplementation of Melatonin Protects against Fibromyalgia-Related Skeletal Muscle Alterations in Reserpine-Induced Myalgia Rats
por: Favero, Gaia, et al.
Publicado: (2017)

Melatonin Modulation of Sirtuin-1 Attenuates Liver Injury in a Hypercholesterolemic Mouse Model
por: Bonomini, Francesca, et al.
Publicado: (2018)

Promising Antineoplastic Actions of Melatonin
por: Favero, Gaia, et al.
Publicado: (2018)

Effects of Dietary Oleacein Treatment on Endothelial Dysfunction and Lupus Nephritis in Balb/C Pristane-Induced Mice
por: Muñoz-García, Rocío, et al.
Publicado: (2023)

cGAS deficiency enhances inflammasome activation in macrophages and inflammatory pathology in pristane-induced lupus
por: Kumpunya, Sarinya, et al.
Publicado: (2022)

3β-Acetyloxy-oleanolic Acid Attenuates Pristane-Induced Lupus Nephritis by Regulating Th17 Differentiation
por: Zhou, Xiaoqing, et al.
Publicado: (2019)

Procyanidin B2 prevents lupus nephritis development in mice by inhibiting NLRP3 inflammasome activation
por: He, Junhui, et al.
Publicado: (2018)

CD36 aggravates podocyte injury by activating NLRP3 inflammasome and inhibiting autophagy in lupus nephritis
por: Lv, Fu, et al.
Publicado: (2022)

MicroRNA 155-deficiency leads to decreased autoantibody levels and reduced severity of nephritis and pneumonitis in pristane-induced lupus
por: Leiss, Harald, et al.
Publicado: (2017)

The Impact of Melatonin Supplementation and NLRP3 Inflammasome Deletion on Age-Accompanied Cardiac Damage
por: Sayed, Ramy K. A., et al.
Publicado: (2021)

Pristane induced lupus mice as a model for neuropsychiatric lupus (NPSLE)
por: Yun, Yang, et al.
Publicado: (2023)

Maintenance of autoantibody production in pristane-induced murine lupus
por: Han, Shuhong, et al.
Publicado: (2015)

Therapeutic Effects of Tofacitinib on Pristane-Induced Murine Lupus
por: LIN, Jiayi, et al.
Publicado: (2022)

Baicalein ameliorates pristane-induced lupus nephritis via activating Nrf2/HO-1 in myeloid-derived suppressor cells
por: Li, Dan, et al.
Publicado: (2019)

The Role of Melatonin on NLRP3 Inflammasome Activation in Diseases
por: Arioz, Burak Ibrahim, et al.
Publicado: (2021)

Aquaporin and Blood Brain Barrier
por: Francesca, Bonomini, et al.
Publicado: (2010)

Hypertension and endothelial dysfunction in the pristane model of systemic lupus erythematosus
por: McClung, Daniel M., et al.
Publicado: (2021)

The DNA co-vaccination using Sm antigen and IL-10 as prophylactic experimental therapy ameliorates nephritis in a model of lupus induced by pristane
por: Martín-Márquez, Beatriz Teresita, et al.
Publicado: (2021)

Oxidative DNA Damage Accelerates Skin Inflammation in Pristane-Induced Lupus Model
por: Tumurkhuu, Gantsetseg, et al.
Publicado: (2020)

Interferon Lambda Regulates Cellular and Humoral Immunity in Pristane-Induced Lupus
por: Aschman, Tom, et al.
Publicado: (2021)

Pineal Gland Tumors: A Review
por: Favero, Gaia, et al.
Publicado: (2021)

Pristane-Accelerated Autoimmune Disease in (SWR X NZB) F1 Mice Leads to Prominent Tubulointerstitial Inflammation and Human Lupus Nephritis-Like Fibrosis
por: Gardet, Agnes, et al.
Publicado: (2016)

Citral alleviates an accelerated and severe lupus nephritis model by inhibiting the activation signal of NLRP3 inflammasome and enhancing Nrf2 activation
por: Ka, Shuk-Man, et al.
Publicado: (2015)

Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane
Publicado: (1994)

Resveratrol Possesses Protective Effects in a Pristane-Induced Lupus Mouse Model
por: Wang, Zhuo-Long, et al.
Publicado: (2014)

Retinoic Acid Exerts Disease Stage-Dependent Effects on Pristane-Induced Lupus
por: Abdelhamid, Leila, et al.
Publicado: (2020)

Dependence on Autophagy for Autoreactive Memory B Cells in the Development of Pristane-Induced Lupus
por: Jang, Albert, et al.
Publicado: (2021)

Insufficient Iron Improves Pristane-Induced Lupus by Promoting Treg Cell Expansion
por: Gao, Xiaofei, et al.
Publicado: (2022)

Disulfiram alleviates pristane-induced lupus via inhibiting GSDMD-mediated pyroptosis
por: Zhuang, Lili, et al.
Publicado: (2022)

Fecal microbiota from MRL/lpr mice exacerbates pristane-induced lupus
por: Yi, Xiaoqing, et al.
Publicado: (2023)

Accelerated and Severe Lupus Nephritis Benefits From M1, an Active Metabolite of Ginsenoside, by Regulating NLRP3 Inflammasome and T Cell Functions in Mice
por: Lin, Tsai-Jung, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6ujvo9lk0vkk7o9sjbf7pd60vd